Cited by 46Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta‐mediated pathology

Open access
Samuels, Joshua D., Moore, Katelyn A., Ennerfelt, Hannah E., Johnson, Alexis M., Walsh, Adeline E., Price, Richard J., Lukens, John R.·2023·Alzheimer's & Dementia

Abstract

Introduction: Mutations in INPP5D, which encodes for the SH2‐domain‐containing inositol phosphatase SHIP‐1, have recently been linked to an increased risk of developing late‐onset Alzheimer's disease. While INPP5D expression is almost exclusively restricted to microglia in the brain, little is known regarding how SHIP‐1 affects neurobiology or neurodegenerative disease pathogenesis. Methods: We generated and investigated 5xFAD Inpp5dfl/flCx3cr1Ert2Cre mice to ascertain the function of microglial SHIP‐1 signaling in response to amyloid beta (Aβ)‐mediated pathology. Results: SHIP‐1 deletion in microglia led to substantially enhanced recruitment of microglia to Aβ plaques, altered microglial gene expression, and marked improvements in neuronal health. Further, SHIP‐1 loss enhanced microglial plaque containment and Aβ engulfment when compared to microglia from Cre‐negative 5xFAD Inpp5dfl/fl littermate controls. Discussion: These results define SHIP‐1 as a pivotal regulator of microglial responses during Aβ‐driven neurological disease and suggest that targeting SHIP‐1 may offer a promising strategy to treat Alzheimer's disease. Highlights: Inpp5d deficiency in microglia increases plaque‐associated microglia numbers. Loss of Inpp5d induces activation and phagocytosis transcriptional pathways. Plaque encapsulation and engulfment by microglia are enhanced with Inpp5d deletion. Genetic ablation of Inpp5d protects against plaque‐induced neuronal dystrophy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.13089

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Keren-Shaul H, Spinrad A, Weiner A, et al. A unique microglia type associated with restricting development of Alzheimer's dis- ease. Cell. 2017;169:1276-1290. doi: 10.1016/J.CELL.2017.05.018/ ATTACHMENT/63D76284-8C53-4D00-93AA-E1E70B1AE6DE/ MMC7.XLSX. e17. · DOI
  2. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45:1452. doi: 10.1038/NG.2802 · DOI · Paper page
  3. Bellenguez C, Küçükali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022;54:412-436. doi: 10.1038/s41588-022-01024-z · DOI · Paper page
  4. Jing H, Zhu J-X, Wang H-F, et al. INPP5D rs35349669 poly- morphism with late-onset Alzheimer's disease: a replication study and meta-analysis. Oncotarget. 2016;7:69225-69230. doi: 10.18632/ ONCOTARGET.12648 · DOI · Paper page
  5. Ando K, Erneux C, Homa M, et al. Dysregulation of Phosphoinosi- tide 5-phosphatases and phosphoinositides in Alzheimer's Disease. Front Neurosci. 2021;15:126. doi: 10.3389/FNINS.2021.614855/BIB TEX · DOI
  6. Pauls SD, Marshall AJ. Regulation of immune cell signaling by SHIP1: a phosphatase, scaffold protein, and potential therapeutic target. Eur J Immunol. 2017;47:932-945. doi: 10.1002/EJI.2016467 95 · DOI · Paper page
  7. Mondal S, Subramanian KK, Sakai J, Bajrami B, Fernandes S, et al. SHIP- 1 couples to the dectin-1 hemITAM and selectively modulates reactive oxygen species production in dendritic cells in response to Candida albicans. J Immunol. 2015;195:4466-4478. doi: 10.4049/JIMMUNOL. 1402874/-/DCSUPPLEMENTAL · DOI
  8. Saz-Leal P, del Fresno C, Brandi P, et al. Targeting SHIP-1 in myeloid cells enhances trained immunity and boosts response to infection. Cell Rep. 2018;25:1118-1126. doi: 10.1016/J.CELREP.2018.09.092 · DOI
  9. Kamen LA, Levinsohn J, Cadwallader A, Tridandapani S, Swanson JA. SHIP-1 increases early oxidative burst and regulates phagosome mat- uration in macrophages. J Immunol. 2008;180:7497-7505. doi: 10. 4049/JIMMUNOL.180.11.7497 · DOI
  10. Qin S, Li J, Zhou C, Privratsky B, et al. SHIP-1 Regulates phagocyto- sis and M2 polarization through the PI3K/Akt-STAT5-Trib1 circuit in pseudomonas aeruginosa infection. Front Immunol. 2020;11:307. doi: 10.3389/FIMMU.2020.00307/BIBTEX · DOI
  11. Ye X, Zhang F, Zhou L, et al. Selective deletion of SHIP-1 in hematopoi- etic cells in mice leads to severe lung inflammation involving ILC2 cells. Sci Rep. 2021;11:1-14. doi: 10.1038/s41598-021-88677-8 · DOI
  12. Poe JC, Fujimoto M, Jansen PJ, Miller AS, Tedder TF. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. J Biol Chem. 2000;275:17420-17427. doi: 10.1074/jbc.m001892200 · DOI
  13. Mkaddem SB, Benhamou M, Monteiro RC. Understanding Fc receptor involvement in inflammatory diseases: from mechanisms to new thera- peutic tools. Front Immunol. 2019;10:811. doi: 10.3389/FIMMU.2019. 00811/BIBTEX · DOI
  14. Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB. TREM2-and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 2010;3:ra38. doi: 10.1126/ SCISIGNAL.2000500/SUPPL_FILE/3_RA38_SM.PDF · DOI
  15. Tsai AP, Lin PBC, Dong C, et al. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia. Neurobiol Dis. 2021;153:105303. doi: 10.1016/J.NBD.2021. 105303 · DOI · Paper page
  16. Wang JW, Howson JM, Ghansah T, et al. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Sci- ence. 2002;295:2094-2097. doi: 10.1126/SCIENCE.1068438/SUPPL_ FILE/1068440S3_THUMB.GIF 1979 · DOI
  17. Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38:79-91. doi: 10.1016/J.IMMUNI.2012.12.001 · DOI · Paper page
  18. Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573-3587. doi: 10.1016/J.CELL.2021.04.048/ATTACHMENT/1E5EB5C1-59EE- 4B2B-8BFA-14B48A54FF8F/MMC3.XLSX. e29. · DOI
  19. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1-21. doi: 10.1186/S13059-014-0550-8/FIGURES/9 · DOI
  20. Xie Z, Bailey A, Kuleshov MV, et al. Gene set knowledge discovery with enrichr. Curr Protoc. 2021;1:e90. doi: 10.1002/CPZ1.90 · DOI · Paper page
  21. Clarke DJB, Jeon M, Stein DJ, et al. Appyters: turning Jupyter Note- books into data-driven web apps. Patterns. 2021;2:100213. doi: 10. 1016/j.patter.2021.100213 · DOI
  22. Nagayach A, Patro N, Patro I. Microglia in the physiology and pathology of brain. Proc Natl Acad Sci, India, Sect B Biol Sci. 2015;86:781-794. doi: 10.1007/S40011-015-0585-Y 35. Kumar S, Budhathoki S, Oliveira CB, et al. Role of the Caspase- 8/RIPK3 axis in Alzheimer's disease pathogenesis and Aβ-induced NLRP3 inflammasome activation. JCI Insight. 2023;8(3):e157433. doi: 10.1172/JCI.INSIGHT.157433 · DOI
  23. Sengupta U, Nilson AN, Kayed R. The role of amyloid-β Oligomers in Toxicity, propagation, and immunotherapy. EBioMedicine. 2016;6:42. doi: 10.1016/J.EBIOM.2016.03.035 · DOI · Paper page
  24. Zhou Y, Song WM, Andhey PS, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020;26:131-142. doi: 10.1038/s41591-019-0695-9 · DOI · Paper page
  25. Walker DG, Lue LF. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polar- ization in human brains. Alzheimers Res Ther. 2015;7:1-9. doi: 10.1186/ S13195-015-0139-9/FIGURES/2 · DOI
  26. Yuan P, Condello C, Keene CD, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724-739. doi: 10.1016/J.NEURON.2016.05.003 · DOI · Paper page
  27. Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques. Nat Commun. 2015;6:1-14. doi: 10.1038/ncomms7176 · DOI · Paper page
  28. Wang S, Sudan R, Peng V. TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways. Cell. 2022;185:4153-4169. doi: 10.1016/J.CELL.2022.09.033. e19. · DOI · Paper page
  29. Lyra e Silva NM, Gonçalves RA, Pascoal TA, et al. Pro-inflammatory interleukin-6 signaling links cognitive impairments and periph- eral metabolic alterations in Alzheimer's disease. Transl Psychiatry. 2021;11:1-15. doi: 10.1038/s41398-021-01349-z · DOI
  30. Qu W, Tian D, Guo Z, et al. Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary dam- age in rats after spinal cord injury. J Neuroinflammation. 2012;9:1-14. doi: 10.1186/1742-2094-9-178/FIGURES/7 · DOI
  31. Huang WC, Yen FC, Shie FS, et al. TGF-β1 blockade of microglial chemotaxis toward Aβ aggregates involves SMAD signaling and down- regulation of CCL5. J Neuroinflammation. 2010;7:1-11. doi: 10.1186/ 1742-2094-7-28/FIGURES/5 · DOI

Cited by

Sorted by citations

Authors
Samuels, J. D., Moore, K. A., Ennerfelt, H. E., Johnson, A. M., Walsh, A. E., Price, R. J., & Lukens, J. R.
Affiliations
University of Virginia (US)
Corresponding author
Lukens, John R.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2023-04-15
Volume
19
Issue
11
Pages
4908-4921
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W4365815492
Cited by
46
References
16
Citations by year
2026: 15 · 2025: 14 · 2024: 9 · 2023: 8
FWCI
4.74
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Alzheimer's Association (ADSF-21-816651)
  • Cure Alzheimer's Fund
  • Owens Family Foundation
  • National Institutes of Health (NIH T32)
  • National Institute on Aging (RF1AG071996)
  • National Institute of General Medical Sciences (T32GM008715)
  • National Institute of Neurological Disorders and Stroke (R01NS106383, R01NS111102, T32NS115657)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB030744)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
INPP5D, SHIP1
MeSH terms
Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Alzheimer Disease, Animals, Disease Models, Animal, Mice, Transgenic, Risk Factors, Amyloid beta-Peptides, Microglia, Neurodegenerative Diseases, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review